AOD-9604 in Australia: Legal Status & Evidence
Evidence limitations and individual safety require clinical assessment. Registration and lawful supply must be checked; this information is not a treatment recommendation.
Short answer: AOD-9604 is not an ARTG-registered finished medicine. A website listing does not establish safety, clinical suitability or lawful supply.
Overview
AOD-9604 is a modified fragment of growth hormone investigated in metabolic research. Its research history does not establish an approved Australian indication or an individual treatment benefit.
Australian regulatory status
AOD-9604 is not an ARTG-registered finished medicine. A website listing does not establish safety, clinical suitability or lawful supply.
Registration and exceptional access are different
ARTG registration applies to a specific product and its approved indications. An eligible unapproved medicine may instead require a TGA application and approval before supply, or Authorised Prescriber authorisation. Neither pathway is an endorsement, a finding of suitability for everyone, or an override of supply prohibitions.
Evidence and uncertainty
Laboratory and animal findings cannot establish patient outcomes. Small or early studies may not identify uncommon harms, interactions or long-term risks. Research on one formulation or population cannot automatically be applied to another. This page does not rank treatments or recommend a medicine.
Safety questions for an individual assessment
A registered doctor considers symptoms, medical history, current medicines, allergies and any necessary investigations. Pregnancy, breastfeeding, cancer history and other health conditions may change the assessment. Potential interactions and the limits of available evidence need to be discussed. Do not start, combine or adjust medicines based on online information.
Unregulated products and importation
A research-only label does not establish quality or lawful therapeutic supply. Identity, concentration and sterility may be unverified. Personal importation has conditions and restrictions; check the official TGA guidance rather than relying on a seller's claims. A prescription is not an automatic exemption from every restriction.
Clinical decisions and follow-up
Whether any treatment is appropriate is a decision for a registered doctor after an individual assessment. Monitoring and follow-up depend on the person and the product; there is no universal timetable or promised outcome. Questions about symptoms or suspected adverse effects should be directed to a health practitioner. In an emergency, call 000.
Indications reviewed at consultation
- Medical history, allergies and previous treatment
- Current medicines and potential interactions
Administration
AOD-9604 research does not establish an approved Australian treatment; a product listing is not clinical guidance.
Cautions
Not for use in pregnancy, breastfeeding, or active cancer. Not a substitute for diet and exercise; requires prescriber review.
Frequently asked questions
- Is AOD-9604 legal in Australia?
- AOD-9604 is not an ARTG-registered medicine. Its research status does not authorise over-the-counter sale or bypass Australian therapeutic-goods restrictions.
- What safety and evidence questions need assessment?
- Relevant questions include the quality of human studies, possible interactions, medical conditions that affect risk and gaps in long-term safety information.
Educational content only. Whether any treatment is appropriate, and whether it can lawfully be supplied in Australia, is a decision for a registered doctor and the TGA.
General information only, not medical advice. The treating doctor decides whether any treatment is appropriate.
Important information
Official sources — regulatory context
- TGA: pharmacy compounding changes from 1 October 2024
- TGA: peptide regulation and unapproved medicines
- TGA: access pathways for unapproved therapeutic goods
- AHPRA: health advertising and evidence requirements
These sources explain medicine regulation, access and health advertising requirements; they do not endorse this site. An educational disclaimer does not establish compliance or replace advice from a registered clinician.
Related peptides
Australian consultation information by city
Questions about your options?
Learn how a telehealth consultation with an AHPRA-registered Australian doctor works. Whether any treatment is appropriate is a decision your doctor makes based on your individual clinical needs.
How Australian access pathways work